Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Transcenta to Present Three Study Results at ESMO 2023 2023-08-16 08:00
Infinitus and Jiangnan University Establish an Innovation Research Center to Explore the Combination of Chinese Herbal Medicine and Probiotics 2023-08-16 08:00
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency 2023-08-16 01:00
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis 2023-08-15 22:50
CStone Pharmaceuticals Reports 2023 Interim Results and Updates 2023-08-15 22:33
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI) 2023-08-15 20:19
Former U.S. Representative Patrick J. Kennedy Joins Holmusk as a Strategic Advisor 2023-08-15 20:00
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors 2023-08-15 20:00
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System 2023-08-15 16:52
Waterdrop's AI-powered Conversational Platform Clinches Top Prize at 2023 Inslab Insurance Technology Innovation Competition 2023-08-15 12:53
Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM 2023-08-15 09:00
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan 2023-08-14 21:30
Orthopedic brace can help reduce pain from Hallux Valgus - The Footing Health K releases Toe braces! 2023-08-14 20:00
Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or above prior standard of care has met its primary endpoint 2023-08-14 12:50
Souper Fond Revolutionises Meal Preparation for Busy Parents with Nourishing Broths 2023-08-14 11:16
International Youth Day 2023: Angel Yeast Paves Path for Young Employees, Supporting Sustainable Talent Development 2023-08-12 20:00
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach 2023-08-11 21:14
Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials 2023-08-11 21:00
1 115 116 117 118 119 1502